Gossamer Bio Q3 EPS $(7.36) Misses $(3.68) Estimate, Sales $38.431M Beat $12.148M Estimate
Benzinga Newsdesk 2 hours ago
NewsEarningsEarnings BeatsEarnings Misses
Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(7.36) per share which missed the analyst consensus estimate of $(3.68) by 100 percent. This is a 3404.76 percent decrease over losses of $(0.21) per share from
Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(7.36) per share which missed the analyst consensus estimate of $(3.68) by 100 percent. This is a 3404.76 percent decrease over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $38.431 million which beat the analyst consensus estimate of $12.148 million by 216.37 percent. This is a 189.09 percent increase over sales of $13.294 million the same period last year.